ACE2 and COVID-19: Furthermore, the elevated expression of ACE2 on vascular endothelial cells has been shown to be the cause of abnormal coagulation with a prothrombotic tendency and associated hypotension observed in patients with COVID-19 during the later stages of the disease [17].